These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 21822549)

  • 1. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan.
    Fang WL; Wu CW; Chen JH; Lo SS; Hsieh MC; Shen KH; Hsu WH; Li AF; Lui WY
    Ann Surg Oncol; 2009 Dec; 16(12):3237-44. PubMed ID: 19636628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction.
    Nakamura M; Iwahashi M; Nakamori M; Naka T; Ojima T; Iida T; Katsuda M; Tsuji T; Hayata K; Mastumura S; Yamaue H
    Am Surg; 2012 May; 78(5):567-73. PubMed ID: 22546130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence patterns of esophagogastric junction adenocarcinoma according to Siewert's classification after radical resection.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Honda M; Kaito A; Daiko H; Kinoshita T
    Anticancer Res; 2014 Aug; 34(8):4391-7. PubMed ID: 25075076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
    Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
    Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
    G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prognostic compatibility between seventh AJCC/TNM of the esophagus and 14th JCGC staging systems in Siewert type II adenocarcinoma.
    Kawaguchi T; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
    Anticancer Res; 2013 Aug; 33(8):3461-5. PubMed ID: 23898120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
    Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
    Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenocarcinoma of the esophagogastric junction in Japan.
    Yamamoto M; Baba H; Egashira A; Oki E; Ikebe M; Kakeji Y; Maehara Y
    Hepatogastroenterology; 2008; 55(81):103-7. PubMed ID: 18507087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.
    Kurokawa Y; Hiki N; Yoshikawa T; Kishi K; Ito Y; Ohi M; Wada N; Takiguchi S; Mine S; Hasegawa S; Matsuda T; Takeuchi H
    Surgery; 2015 Mar; 157(3):551-5. PubMed ID: 25532434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review.
    Aurello P; D'Angelo F; Nigri G; Bellagamba R; Cicchini C; Ruzzetti R; Ramacciato G
    Am Surg; 2006 Feb; 72(2):118-23. PubMed ID: 16536239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.
    Hasegawa S; Yoshikawa T; Cho H; Tsuburaya A; Kobayashi O
    World J Surg; 2009 Jan; 33(1):95-103. PubMed ID: 18958523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
    von Rahden BH; Stein HJ; Feith M; Becker K; Siewert JR
    J Clin Oncol; 2005 Feb; 23(4):874-9. PubMed ID: 15681533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition.
    Meier I; Merkel S; Papadopoulos T; Sauer R; Hohenberger W; Brunner TB
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1408-17. PubMed ID: 18374226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.